PharmiWeb.com - Global Pharma News & Resources
30-Jan-2025

Lhasa Limited acquires Molecular Networks and Altamira, leaders in chemoinformatics

Improving offerings across the chemical, biotechnology, pharmaceutical, and most notably, the cosmetics industry.

Lhasa Limited, a UK not-for-profit organisation that creates world-leading software solutions to support decision making on chemical safety, is delighted to announce the acquisition of Molecular Networks GmbH and Altamira, LLC.

Molecular Networks (MN), based in Germany, and US-based Altamira (AM) are known for innovation and excellence in cheminformatics, with a focus on scientific software applications for in silico profiling and evaluation of chemical compounds.

Molecular Networks (MN-AM) software products are used worldwide in industry and academic research, to design and optimise chemical products and processes. One of their flagship products, ChemTunes·ToxGPS, a safety assessment system that integrates data and knowledge from experiments and predictions, is widely used for safety assessments within the cosmetics industry. The system includes chemical, biological, and safety data based on a high-quality dataset developed in collaboration with the FDA and the EU SEURAT-1 Research Initiative, within via COSMOS project.

Dr Chris Barber, CEO of Lhasa Limited, says: "We have worked alongside Molecular Networks and Altamira for a number of years. I’ve always been impressed with their approach and their scientific software products. This is a great opportunity, which will benefit our collective community, alongside supporting our charitable purpose of advancing chemical safety science and reducing the need for animal testing."

Lhasa have a long-standing relationship with Molecular Networks and Altamira, having successfully collaborated on several EU funded projects. The acquisitions will broaden the chemical safety assessment impact, delivering additional value to Lhasa members, MN-AM’s clients and stakeholders.

Dr Chihae Yang, CEO and Founder of MN-AM, says: "We are thrilled to join Lhasa Limited. We share a common vision and mission with Lhasa, to provide high-quality scientific software products and services that support the scientific community and society. I look forward to working together to realise the full potential of in silico approaches for assessing the safety of chemicals. "

 

Company bio

Lhasa Limited is a not-for-profit organisation driven by a clear purpose: to enable informed decision making on chemical safety.

Lhasa creates recognised and trusted software solutions that solve real-world chemical safety assessment problems in relation to drugs, chemicals and cosmetics. Flagship in silico solutions include Derek Nexus for toxicity prediction, Sarah Nexus for mutagenicity assessment, and Zeneth for degradation prediction. Lhasa technology is designed by scientists, for scientists, in collaboration with industry stakeholders and regulators.

 

Useful links

Lhasa Limited website

Lhasa Limited contact page and email: Hello@lhasalimited.org

MN-AM website

 

PR contact info

Ally Reeves, Head of Marketing, Lhasa Limited

Ally.reeves@lhasalimited.org

Editor Details

Last Updated: 30-Jan-2025